Abstract:
PURPOSE: A pharmaceutical composition containing Vitis vinifera seed extract is provided to reduce acetone use and to prevent and treat rheumatic arthtritis. CONSTITUTION: A pharmaceutical composition for preventing or treating rheumatic arthritis contains Vitis vinifera seed extract and pharmaceutically acceptable carrier thereof. The extract is obtained by pulverizing Vitis vinifera seeds, extracting the seeds with a mixture solvent of acetone and water, removing acetone and saturating sodium chloride, extracting liquid with ethyl acetate and concentrating, adding chloroform and filtering.
Abstract:
본 발명은 Rcan3를 활성화시키는 항산화제의 신규 용도에 관한 것으로, 자세하게는 Rcan3 유전자 발현을 증가시키는 활성을 갖는 항산화제; 항산화제를 세포에 처리하는 단계를 포함하는 Rcan3 유전자 발현을 증가시키는 방법; 및 Rcan3 단백질을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물에 관한 것이다. 본 발명에 따른 항산화제는 Rcan3의 유전자 발현을 효과적으로 증대시킬 수 있는 신규 용도를 가지므로, 이를 이용하여 Rcan3 단백질을 용이하게 증폭시킬 수 있고, 이렇게 증폭된 Rcan3 단백질은 칼시뉴린 경로를 억제할 수 있어 면역질환을 예방 또는 치료할 수 있는 면역 억제제로서 유용하게 사용할 수 있다. 또한, 상기 Rcan3 단백질은 천연 단백질로서 독성 및 부작용도 없어 장기간 안심하고 사용할 수 있으며, 체내에 대해 안정한 효과가 있다.
Abstract:
PURPOSE: A composition containing rebamipide for preventing or treating cancer or immune diseases is provided to suppress Th17 cell differentiation and to enhance immune regulatory T cell activity. CONSTITUTION: A composition for preventing or treating cancer or immune diseases contains rebamipid compounds or pharmaceutically acceptable salt thereof as an active ingredient. The immune diseases include autoimmune disease, inflammatory disease, and transplantation rejection. A method for reducing or suppressing differentiation of immature T cells into Th17 cell in vitro comprises a step of treating rebamipid compounds or pharmaceutically acceptable salt thereof.
Abstract:
PURPOSE: A pharmaceutical composition containing Vitis vinifera seed extract and pharmaceutically acceptable carrier is provided to prevent and treat obesity. CONSTITUTION: A pharmaceutical composition for preventing or treating obesity contains Vitis vinifera seed extract and pharmaceutically acceptable carrier. The extract has 80-130 of procyanidolic value(PCV) and contains less than 30% of (+)catechin and (-) epicatechin and 95-105% of proanthocyanidin content. A method for preparing the extract comprises: a step of mixing pulverized Vitis vinifera seed and a mixture solvent of acetone and water and isolating at room temperature; a step of filtering the extract and distilling the filtered liquid to remove acetone; a step of saturating sodium chloride and filtering; a step of extracting the liquid with ethyl acetate and concentrating; and a step of adding chloroform and filtering.
Abstract:
The present invention relates to the pharmaceutical use of rebamipide used for preventing or treating hyperlipidemia and diseases therewith and more specifically, to a composition containing rebemipide as an active ingredient for preventing or treating hyperlipidemia and diseases associated therewith. The rebamipidie compound according to the present invention: suppresses the formation of TNF-a, IL-6, and IL-1b, which are inflammatory cytokines inducing hyperlipidemia and secreted by macrophages; inhibits the generation of foam cells forming atherosclerotic plaque precursor cells; improves blood lipid by reducing the levels of total cholesterol, LDL-cholesterol, and triglycerides in blood; improves a fatty liver; inhibits B cell activities; decreases the expression of Th17 accelerating atherosclerotic plaque formation; and increases the expression of Treg cells controlling the inflammatory response. Thus, the rebamipide compound can be useful as a pharmaceutical composition for preventing or treating hyperlipidemia and diseases associated therewith including atherosclerosis, heart failure, hypertensive cardiac diseases through various mechanisms. Also, the composition has no toxicity or side effect, thereby being safe to use for a long period and stable in the body.